Happy National Chicken Wing Day! Companies known for their well-sauced fried chicken delicacies have pulled out all the stops this year to drive people into their restaurants on the made up holiday. Buffalo Wild Wings (BWLD) -- synonymous for its 21 different sauces and rubs -- is offering half-priced wings on Friday. Hooters, home of scantily clad female waitresses and only OK tasting food, has stepped up to the plate with all-you-can-eat traditional wings and boneless wings for $14.99 and $12.99, respectively. At relative newcomer to the space Wingstop (WING) , it's giving customers who order wings an extra five classic or boneless wings for free between 11 a.m. and 2 p.m. Pretty meaty wing giveaways indeed. But, make no mistake about it, Americans are poised to scoff down saucey chicken wings way more than on a single day this year. An estimated 28 billion traditional bone-in chicken wings are expected to be eaten in 2016, according to the National Chicken Council. TheStreet visited a Buffalo Wild Wings in New York City to get the lowdown on what makes a great wing. In the case of B-Dubs, as it's known with fans of the chain, its popular wings are made so because they aren't composed from frozen chicken. Beyond wings, chicken remains a top dinner or snack choice among consumers trying to watch their waistline. In the next 12 months, says the National Chicken Council, 21 percent of consumers anticipate eating more chicken from the supermarket while 14 percent see themselves consuming more from a food service establishment such as Buffalo Wild Wings. In fact, according to U.S. Department of Agriculture estimates, Americans will eat 92 pounds of chicken per person this year, a record amount. TheStreet's Brian Sozzi reports from a Buffalo Wild Wings in New York City's Times Square.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.